CoChat

Patterns of Glycemia in Normal Pregnancy

Open access
Hernandez, Teri L., Friedman, Jacob E., Van Pelt, Rachael E., Barbour, Linda A. · 2011 · Diabetes Care

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Abstract

Despite the well-known influence of maternal glucose on infant birth weight (BW), the prevalence of large for gestational age (LGA) infants (≥90th percentile for age) has been increasing steadily over decades, particularly in pregnancies complicated by pregestational or gestational diabetes mellitus (1). Although the overall prevalence of macrosomia (BW ≥4,000 g) is 17–29% in women with untreated gestational diabetes, the majority of macrosomic infants are born to women with obesity but no gestational diabetes (2,3). Moreover, epidemiologic data show that a higher BW is associated with higher BMI and glucose intolerance later in life (4,5), suggesting life-long metabolic implications for offspring. Recent data from the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study suggested that concentrations of maternal glucose below the previously accepted diagnostic thresholds for gestational diabetes are predictive of LGA and fetal hyperinsulinemia (6). On the basis of this landmark study, the International Association of Diabetes in Pregnancy Study Group and the American Diabetes Association (ADA) recommended new lower diagnostic criteria for gestational diabetes (7,8). However, a significant number of women with gestational diabetes whose glucose values are within the current targeted therapeutic ranges deliver macrosomic infants (9). Although glucose plays a major role in fetal growth, this paradox underscores the likely role of other nutrients in fetal growth, but also the need to critically reexamine our definition of “normal” maternal patterns of glycemia and the effects on fetal growth. The new diagnostic criteria recommended by the International Association of Diabetes in Pregnancy Study Group and ADA are expected to increase the prevalence of gestational diabetes to 18%. Thus, treatment targets may need to be reevaluated. Historically, the treatment goal in pregnancies complicated by diabetes has been to mimic patterns of glycemia in normal pregnancy (1). Although the HAPO study better defined abnormal …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc11-0241

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 A: Patterns of glycemia in normal pregnancy (gestational week 33.8 ± 2.3) across 11 studies published between 1975 and 2008. One study provided useful information but required exclusion from the figure because data could not be regraphed. Methodologies used diurnal pattern characterization during inpatient admission (five studies), SMBG via reflectance photometry (one study), and CGMS (six studies) (n = 168–255; BMI range 22–28 at time of study). B: Mean pattern of glycemia across 12 studies (n = 168–255) during 33.8 ± 2.3 weeks’ gestation (weighted average ± SD, values rounded to whole numbers for clinical use). Suggested 1- and 2-h PP targets are <122 and <110 mg/dL, respectively.
Figure 1 A: Patterns of glycemia in normal pregnancy (gestational week 33.8 ± 2.3) across 11 studies published between 1975 and 2008. One study provided useful information but required exclusion from the figure because data could not be regraphed. Methodologies used diurnal pattern characterization during inpatient admission (five studies), SMBG via reflectance photometry (one study), and CGMS (six studies) (n = 168–255; BMI range 22–28 at time of study). B: Mean pattern of glycemia across 12 studies (n = 168–255) during 33.8 ± 2.3 weeks’ gestation (weighted average ± SD, values rounded to whole numbers for clinical use). Suggested 1- and 2-h PP targets are <122 and <110 mg/dL, respectively.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 71 references

Research works printed but not linked: 1

  1. Barbour LA Hernandez TL Reece MS Change in fasting triglycerides from early to late gestation are highly predictive of neonatal adiposity independent of maternal BMI (Abstract). Diabetes 2009; 58(Suppl. 1): A84

Cited by

Items 101–176 of 176

Metadata

Authors
Hernandez, T. L., Friedman, J. E., Van Pelt, R. E., & Barbour, L. A.
Affiliations
  • University of Colorado Anschutz (US)
  • Division of Geriatric Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado
Corresponding author
Hernandez, Teri L.
Venue
Diabetes Care
Published
2011-06-17
Volume
34
Issue
7
Pages
1660-1668
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2049736822
Cited by
170
References
70
Citations by year
2026: 5 · 2025: 9 · 2024: 17 · 2023: 10 · 2022: 12 · 2021: 9 · 2020: 11 · 2019: 13 · 2018: 18 · 2017: 8 · 2016: 14 · 2015: 8 · 2014: 14 · 2013: 10 · 2012: 6
FWCI
2.05
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
maternal glycemia, normal pregnancy, gestational diabetes mellitus, macrosomia, large for gestational age, fetal growth, fetal hyperinsulinemia, HAPO study, maternal obesity, birth weight
MeSH terms
Birth Weight, Blood Glucose, Female, Humans, Infant, Newborn, Pregnancy, Pregnancy Complications, Prenatal Exposure Delayed Effects, Body Mass Index, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.